GlobalData on MSN1d
Maze Therapeutics doses first subject in Phase II AKD treatment trial
Maze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...
Pharm Exec12d
Exploring the Advantages of Innovative Early Phase Trial Design
In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...
Wave Life Sciences initiates early stage clinical trial of WVE-007 in obesity
Wave Life Sciences (NASDAQ:WVE) announced clinical trial application approval and initiation of the Phase 1 INLIGHT clinical ...
Radiopharm announces publication of clinical trial data highlighting RAD 101
Radiopharm Theranostic (RADX)s announced the publication of a novel imaging approach demonstrating proof-of-concept for the use of RAD 101 for ...
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new approach for healthy, ...
Morningstar7d
Algiax Announces Positive Data from Phase 2a Proof of Concept Study Evaluating AP-325 in Patients with Neuropathic Pain
Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic neuropathic pain, today announced compelling topline data from its Phase 2a ...
Morningstar5d
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
INLIGHT is a Phase 1, first-in-human clinical trial ... guidance on developing therapeutics for weight reduction. Proof-of-concept clinical data from INLIGHT, including safety, tolerability ...